Back

Effectivity and adherence of secondary prevention on clinical outcome of rheumatic heart disease in high-burden setting: a systematic review and meta-analysis

28 August 2023 (13:15 - 13:45)
Organised by: Logo
Congress Presentation Part of: Cardiovascular disease in primary care Cardiovascular Disease in Primary Care ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Brian Mendel

National Cardiovascular Center Harapan Kita, Jakarta (Indonesia)

5 More presentations in this session

Presentation thumbnail
Increased risk of decompensated heart failure, acute coronary syndrome, arrythmias and ischemic stroke following exacerbation of COPD: results from a multi-database cohort study
Doctor N. Hawkins (Vancouver, CA)
Abstract Slides Video
Presentation thumbnail
Detection of hidden cases of familial hypercholesterolemia in the Netherlands: a central laboratory data-driven strategy
Ms S. Ibrahim (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
A change in risk assessment for treatment with statins in patients with familial hypercholesteremia and Gilbert's syndrome
Doctor D. Brown (Provo, US)
Abstract Slides Video
Presentation thumbnail
Cardiovascular disease screening in homeless individuals-a feasibility study
Professor A. Banerjee (London, GB)
Abstract Slides Video
Presentation thumbnail
Higher subclinical cardiac fibrosis in South African youth with HIV: results from the CTAAC-heart study
Doctor J. Jao (Chicago, US)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular disease in primary care

The Event

Event poster

ESC Congress 2023

28 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Rheumatic heart disease and infective endocarditis: current status of diagnosis and therapy
thumbnail
Congress Presentation
Antibiotic prophylaxis for latent rheumatic heart disease
thumbnail
Congress Presentation
Rheumatic heart valve disease and beyond: cardiac manifestations of rheumatic fever and rheumatic heart disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources